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in diameter during March-April. The fruit appears as dark 
purple when ripe enclosing 5-8 large seeds. Ripened fruit 
has agreeable flavor and sweetish acid taste.[4] The literature 
revealed the presence of polyisoprenylated benzophenone 
derivatives, namely garcinol, isogarcinol,[5] and organic 
acids chiefly contain (-)-hydroxycitric acid,[6] in the fruits. 
A small amount of xanthones and xanthone derivatives 
were also reported.[6] The dried rind of G. indica (Kokum) 
is traditionally used as a garnish for curry. In Ayurveda, the 
drug has anthelmintic and cardiotonic properties. Decoction 
of the fruit is used in treatment of diabetes.[7] Studies have 
shown the anti-oxidant and anti-glycation activities of G. 
indica in vitro.[8,9] In this view, we studied the effect of aqueous 
extract of G. indica on GSH in type 2 diabetic rats. 
INTRODUCTION
Oxidative stress is the major cause and consequence 
of type 2 diabetes.[1] Glutathione (GSH), the most 
abundant thiol exists as GSH (reduced form) and GSSG 
(oxidized form) in cells, plays an important role against 
oxidative stress.[2] Depletion of intracellular GSH leads 
to neurodegeneration, myocardial infraction and other 
cardiovascular complications in diabetes.[3] 
Garcinia indica Choisy. (Family: Guttiferae) is an evergreen 
tree found in the tropical rain forests of Western Ghats, 
from Konkan southwards in Mysore, Coorg, and Wynaad 
of India. The tree bears globose to spherical fruits of 4-5 cm 
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ABSTRACT
Significant depletion of glutathione (GSH-reduced form) was observed in type 2 diabetes due to oxidative stress. 
Hence the present study was aimed to investigate a drug which restores GSH along with its anti-diabetic activity. 
Aqueous extract of Garcinia indica at a dose of 100 mg/kg and 200 mg/kg was given orally to streptozotocin-
induced type 2 diabetic rats for a period of 4 weeks. At the end, parameters such as fasting blood glucose, 
postprandial blood glucose, and GSH in blood were analyzed. Aqueous extract of G. indica significantly decreased 
both the fasting and postprandial blood glucose in type 2 diabetic rats. The extract also restored the erythrocyte 
GSH in type 2 diabetic rats. Drug at higher dose, i.e. 200 mg/kg, had a more pronounced effect. Restoring the 
erythrocyte GSH, an intracellular anti-oxidant in diabetes, will be beneficial specially by preventing the risk of 
developing complications.   
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MATERIALS AND METHODS
Collection and authentication of plant drug
Fruits of G. indica Choisy. were collected from Udupi 
located in Karnataka, India. Drug was dried under shade 
at temperature not exceeding 40°C and authenticated 
(Accession No: Fru./B.2/R-3/sp-11) at Department of 
Raw Materials Herbarium and Museum, National Institute 
of Science Communication and Information Resources 
(NISCAIR), New Delhi.
Aqueous extract and phyto-constituents
Dried fruit was grounded into a moderately coarse powder (# 
22) in a domestic electric grinder. One part of the powdered 
drug was boiled with 16 parts of water for a period of 15 
min and filtered through muslin cloth.[7] Filtrate was then 
evaporated under reduced pressure in Rota-rod evaporator 
(Buchi RE 121, Japan). The dried aqueous extract (22.7%) 
was packed in air tight container and stored in a desiccator 
for further studies. Phytochemical analysis[10] of the aqueous 
extract showed the presence of carbohydrates, xanthones as 
C-glycosides, tannins, and citric acid. 
Dose and drug solution––In Ayurveda, 5 g of the 
powdered drug in the form of decoction is used in 
treatment of diabetes.[7] In considering the extractive value 
(22.7%) and rat metabolic rate (6 to 7 times higher than 
humans), we selected 100 mg/kg/day and 200 mg/kg/
day doses of aqueous extract for screening the activity. 
The drug solution was prepared by dissolving the required 
quantity of aqueous extract in distilled water prior to the 
administration. 
Animals
Wistar albino rats (140-160 g) of either sex were housed 
under standard laboratory conditions at temperature 25 ± 
2ºC and 55 ± 5 % relative humidity with a regular 12 h light: 
12 h dark cycle. Animals were given standard rat pellet and 
tap water ad libitum. The study protocol (Protocol number: 
IAEC/ 2004/ 06) was approved by Institutional Animal 
Ethical Committee (IAEC). 
Streptozotocin induced neonatal rat model for type 
2 diabetes 
Type 2 diabetes was induced by administering streptozotocin 
(90 mg/kg i.p.) in two-day-old neonatal rats. After 6 weeks 
of streptozotocin injection, rats showing the fasting blood 
glucose more than 160 mg/dl were considered as type 2 
diabetes positive.[11,12] 
Experimental groups
Wistar albino rats of either sex were randomly allotted 
into five groups of six animals (n=6) each. Equal number 
of males and females were maintained in each group and 
caged separately. Group I served as normal and received 
distilled water. Group II served as type 2 diabetic control 
and received distilled water. Group III was type 2 diabetic 
treated with 100 mg/kg of aqueous extract of G. indica. 
Group IV was type 2 diabetic treated with 200 mg/kg of 
aqueous extract of G. indica.[7] Group V was type 2 diabetic 
treated with 10 mg/kg of gliclazide.[13] Drug treatment was 
done on every day morning with the help of oral catheter 
for a period of 4 weeks.[14] Body weight was determined 
at the end of every week. After 4 weeks, the parameters 
such as fasting blood glucose, postprandial blood glucose, 
and GSH in blood were analyzed.
Estimation of fasting blood glucose 
Blood samples were withdrawn from overnight fasted 
animals by retro-orbital puncture and centrifuged at 3000 
rpm for 15 min, at 4°C in cooling centrifuge (Remi, C-24 
BL, Mumbai, India). Glucose in serum was estimated by the 
glucose oxidase and peroxidase (GOD-POD kit) method.[15]
Estimation of postprandial blood glucose 
Overnight fasted animals were treated with respective drug 
solutions. Thirty minutes after the drug treatment, glucose 
solution at a dose of 2.5 g/kg body weight was administered 
orally with the help of a oral catheter. Blood samples were 
withdrawn after 120 min of oral glucose load (postprandial) 
and estimated the serum glucose by the glucose oxidase 
and peroxidase (GOD-POD kit) method.[16] 
Estimation of GSH in blood
0.2 ml of blood withdrawn from overnight fasted animals 
was added into 1.8 ml of distilled water. 3.0 ml of 
precipitating solution [1.67 g of glacial metaphosphoric 
acid, 0.2 g of disodium ethylene-diamine tetra-acetic acid 
(EDTA) and 30 g of sodium chloride dissolved in 100 ml 
distilled water] was added to the hemolysate and filtered. 
To 0.2 ml of the filtrate, 0.8 ml of phosphate solution 
(0.3 M Na2HPO4) and 0.1 ml of DTNB [5, 5’ dithiobis-
2-nitrobenzoic acid] reagent were added. A stable yellow 
color formed was measured colorimetrically at 412 nm.[17] 
GSH in a sample was analyzed by using standard curve. 
Statistical analysis
Data are expressed as mean ± SEM. Statistical comparison J Young Pharm Vol 2 / No 3  267
between different groups was done using One-way analysis 
of variance (ANOVA) followed by the Tukey-Kramer 
multiple comparison test. P<0.05 was considered as 
statistically significant. 
RESULTS
Effect on body weight
Two weeks of drug treatment significantly (P<0.05) 
improved the body weight of diabetic rats. Progress in weight 
gain of drug treated rats was continued for 4 weeks. By the 
end of fourth week, 100 mg/kg and 200 mg/kg dose of 
aqueous extract of G. indica showed 30.2% and 37.7% of 
relative weight gain respectively as compared to the diabetic 
control group. Gliclazide showed 72% gain in body weight. 
Body weight of various experimental groups initially i.e. 
before drug treatment and at the end of first, second, third, 
and fourth weeks of drug treatment is shown in Figure 1. 
Effect on fasting and postprandial blood glucose
Aqueous extract of G. indica at both doses, i.e. 100 
mg/kg and 200 mg/kg, showed a significant (P<0.001) 
decrease in fasting blood glucose of type 2 diabetic rats. 
Difference in-between 100 mg/kg and 200 mg/kg dose 
was found to be significant (P<0.05) when analyzed 
for inter-group comparison, indicating that the drug at 
higher dose will be better effective. Elevated postprandial 
blood glucose of type 2 diabetic rats was significantly 
(P<0.001) decreased with the drug treatment [Table 1]. 
However, the aqueous extract of G. indica at both doses 
was unable to maintain the postprandial blood glucose 
below 140 mg/dl (normal). 
Effect on GSH
Aqueous extract of G. indica with 100 mg/kg dose increased 
the erythrocyte GSH at P<0.01 level of significance and 
200 mg/kg dose increased the erythrocyte GSH at P<0.001 
level of significance. Higher dose of the extract had a 
more pronounced effect on restoring the erythrocyte GSH 
in type 2 diabetic rats. Statistical data of GSH in various 
experimental groups is shown in Table 1. GSH is expressed 
as µ moles to that of hemoglobin (g) measured in each 
blood sample.
DISCUSSION
Most of the currently available anti-diabetic therapies 
reduce the fasting blood glucose but have a little impact 
on postprandial hyperglycemia. Postprandial hyperglycemia 
is an independent risk factor for cardiovascular diseases.[18] 
Aqueous extract of G. indica had a significant (P<0.001) 
effect on both fasting and postprandial hyperglycemia 
of type 2 diabetic rats. Although unable to maintain the 
normal levels in case of postprandial hyperglycemia, i.e. 
140 mg/dl, the extract had a marked effect on elevated 
glucose levels. The extract at higher dose has more 
pronounced effect on type 2 diabetes. Body weight of 
type 2 diabetic rats was found to be less during the course 
of development as compared to normal animals. Weight 
loss in diabetes is generally due to continuous excretion 
of glucose from the body.[19] Improved body weight of 
Table 1: Effect of aqueous extract of Garcinia indica on blood glucose and GSH in type 2 diabetic rats
Group (n=6) Fasting blood glucose 
(mg/dl)
Postprandial blood 
glucose (mg/dl)
GSH  
(µ moles/g Hb)
 Normal 87.05 ± 2.71 114.82± 3.3 6.54 ± 0.12
Type 2 diabetic control 189.78 ± 3.64 305.33± 8.02 4.17 ± 0.12
Type 2 diabetic treated with 100 mg/kg of G. indica 142.16 ± 3.36** 185.33± 4.26** 4.95 ± 0.42*
Type 2 diabetic treated with 200 mg/kg of G. indica 127.33 ± 3.42** 157.05 ± 3.81** 5.58 ± 0.15**
Type 2 diabetic treated with 10 mg/kg of gliclazide 105.54 ± 2.35** 132.66 ± 3.74**
Values are expressed as mean ± SEM;*P<0.01, **P<0.001, significantly different as compared to diabetic control 
Figure 1: Effect of aqueous extract of Garcinia indica on body weight of 
type 2 diabetic rats [NR-Normal; DC = Type 2 diabetic control; Gc100-
Type 2 diabetic treated with 100 mg/kg of aqueous extract of G. indica; 
Gc200-type 2 diabetic treated with 200 mg/kg of aqueous extract of G. 
indica; GLZ-type 2 diabetic treated with 10 mg/kg of gliclazide]. Values 
are expressed as mean ± SEM.
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the treated animals indicates the efficacy of G. indica in 
controlling the glucose excretion and blood glucose level 
of type 2 diabetic rats. In hyperglycemia, auto-oxidation 
of glucose increases the formation of free radicals 
beyond the capacity of defense system to neutralize it and 
cause oxidative stress.[1] One of the major etiologies in 
pathogenesis of diabetic complications is oxidative stress. 
Complications account for disabilities and high mortality 
rates in diabetes.[3] Aerobic cells are endowed with extensive 
antioxidant defense mechanisms including both low 
molecular weight scavengers such as reduced glutathione 
(GSH), ascorbic acid (vitamin C), Vitamin E and enzyme 
system such as superoxide dismutase (SOD), catalase 
(CAT) and glutathione peroxidase (GSH-Px).[2] A non-
enzymatic endogenous antioxidant GSH (reduced form) 
plays an important role against oxidative stress in diabetes. 
Significant (P<0.001) depletion of GSH was observed in 
type 2 diabetic rats as compared to normal group due to 
oxidative stress. Treatment with the aqueous extract of G. 
indica enabled the rats to restore GSH. The drug at 200 mg/
kg dose has better effect on restoring the GSH in type 2 
diabetic rats. Aqueous extract of G. indica contain 12-15% 
of total organic acids of which chief constituent is the 
(-)-hydroxycitric acid.[4,20] These organic acids which act as 
strong antioxidants may be responsible for preventing the 
depletion of GSH under stress conditions. Anti-oxidant 
potential of garcinol[8,9] present in G. indica may also be 
responsible for GSH restoration in type 2 diabetic rats. 
Isolated (-)-hydroxycitric acid has been reported to posses 
regulatory effect on carbohydrate and lipid metabolism. [20] 
It limits the availability of acetyl-CoA required for fatty 
acid synthesis and promotes glycogenesis, β-oxidation, etc. 
These metabolic pathways initiate the uptake of glucose 
by the muscle and thereby combat insulin resistance of 
type 2 diabetes.[14] Marked reduction in the fasting and 
postprandial hyperglycemia by the aqueous extract of 
G. indica may be related to the above regulatory effects 
of drug on metabolism. Further studies on G. indica in 
diabetes-related complications will assure the potential 
benefit of multidimensional activity of the plant drug in 
type 2 diabetes. 
CONCLUSION
G. indica an Ayurvedic drug having anti-diabetic activity 
along with GSH restoration is beneficial in treatment 
of type 2 diabetes specially by preventing the risk of 
developing complications. 
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